Value of imaging progress in precise axillary treatment of breast cancer

doi:10.3877/cma.j.issn.1674-0785.2022.11.005

Abstract

Abstract:

With the reformation of axillary management for patients with newly diagnosed breast cancer, imaging only being used for diagnosis of lymph node metastases hardly meets the requirement of clinical need. The role of imaging is to assess the axillary nodal involvement at baseline, to monitor the in vivo nodal response to drug therapy, and finally to help determine the surgical technique to perform based on the final imaging findings after systemic neoadjuvant treatment. This paper briefly introduces the imaging features of metastatic lymph nodes in breast cancer, the relative advantages and limitations of various imaging methods, and reviews the important clinical trials involving axillary management of breast cancer.

Key words: Breast neoplasms, Breast cancer, Sentinel lymph node, Ultrasound

Yilin Xu, Hong Lu, Xuejing Liu, Yujuan Hao, Ziling Yu, Ying Zhu. Value of imaging progress in precise axillary treatment of breast cancer[J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(11): 1054-1061.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2022.11.005

https://zhlcyszz.cma-cmc.com.cn/EN/Y2022/V16/I11/1054

References 106

1	Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial [J]. Lancet Oncol, 2010, 11(10):927-933.
2	Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial [J]. JAMA, 2017, 318(10):918-926.
3	Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial [J]. Lancet Oncol, 2018, 19(10):1385-1393.
4	Yan M, Abdi MA, Falkson C. Axillary management in breast cancer patients: a comprehensive review of the key trials [J]. Clin Breast Cancer, 2018, 18(6):e1251-1251e1259.
5	刘荫华, 周斌, 辛灵, 等. 正确认识AJCC第8版乳腺癌预后分期的临床价值 [J].国际外科学杂志, 2017, 44(03):149-151.
6	Giuliano AE, Connolly JL, Edge SB, et al. Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual [J]. CA Cancer J Clin, 2017, 67(4):290-303.
7	Chang JM, Leung J, Moy L, et al. Axillary Nodal Evaluation in Breast Cancer: State of the Art [J]. Radiology, 2020, 295(3):500-515.
8	Chung HL, Le-Petross HT, Leung J. Imaging updates to breast cancer lymph node management [J]. Radiographics, 2021, 41(5):1283-1299.
9	Gradishar WJ, Moran MS, Abraham J, et al. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology [J]. J Natl Compr Canc Netw, 2022, 20(6):691-722.
10	叶京明, 郭宝良, 张建国, 等. 中国早期乳腺癌前哨淋巴结活检手术临床实践指南(2022版) [J].中国实用外科杂志, 2022, 42(02):137-145.
11	Riedel F, Schaefgen B, Sinn HP, et al. Diagnostic accuracy of axillary staging by ultrasound in early breast cancer patients [J]. Eur J Radiol, 2021, 135:109468.
12	Upadhyaya VS, Lim GH, Chan E, et al. Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging [J]. Breast J, 2020, 26(2):162-167.
13	Lee B, Lim AK, Krell J, et al. The efficacy of axillary ultrasound in the detection of nodal metastasis in breast cancer [J]. AJR Am J Roentgenol, 2013, 200(3):W314-320.
14	Bedi DG, Krishnamurthy R, Krishnamurthy S, et al. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study [J]. AJR Am J Roentgenol, 2008, 191(3):646-652.
15	Baruah BP, Goyal A, Young P, et al. Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer [J]. Br J Surg, 2010, 97(5):680-683.
16	Abe H, Schacht D, Sennett CA, et al. Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer [J]. AJR Am J Roentgenol, 2013, 200(3):696-702.
17	Cho N, Moon WK, Han W, et al. Preoperative sonographic classification of axillary lymph nodes in patients with breast cancer: node-to-node correlation with surgical histology and sentinel node biopsy results [J]. AJR Am J Roentgenol, 2009, 193(6):1731-1737.
18	Nottegar A, Veronese N, Senthil M, et al. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis [J]. Eur J Surg Oncol, 2016, 42(7):919-925.
19	Yang WT, Chang J, Metreweli C. Patients with breast cancer: differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes [J]. Radiology, 2000, 215(2):568-573.
20	Abe H, Schmidt RA, Kulkarni K, et al. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients [J]. Radiology, 2009, 250(1):41-49.
21	Zhu Y, Zhou W, Jia XH, et al. Preoperative axillary ultrasound in the selection of patients with a heavy axillary tumor burden in early-stage breast cancer: what leads to false-positive results? [J]. J Ultrasound Med, 2018, 37(6):1357-1365.
22	Di Micco R, Zuber V, Fiacco E, et al. Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype [J]. Eur J Surg Oncol. 2019, 45(6):969-975.
23	Morrow E, Lannigan A, Doughty J, et al. Population-based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node-positive invasive lobular carcinoma of the breast [J]. Br J Surg, 2018, 105(8):987-995.
24	Neal CH, Daly CP, Nees AV, et al. Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer? [J]. Radiology, 2010, 257(2):335-341.
25	Barroso-Sousa R, Metzger-Filho O. Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications [J]. Ther Adv Med Oncol, 2016, 8(4):261-266.
26	Ecanow JS, Abe H, Newstead GM, et al. Axillary staging of breast cancer: what the radiologist should know [J]. Radiographics, 2013, 33(6):1589-1612.
27	Rao R, Lilley L, Andrews V, et al. Axillary staging by percutaneous biopsy: sensitivity of fine-needle aspiration versus core needle biopsy [J]. Ann Surg Oncol, 2009, 16(5):1170-1175.
28	Vidya R, Iqbal FM, Bickley B. Pre-operative axillary staging: should core biopsy be preferred to fine needle aspiration cytology? [J]. Ecancermedicalscience, 2017, 11:724.
29	Rahbar H, Partridge SC, Javid SH, et al. Imaging axillary lymph nodes in patients with newly diagnosed breast cancer [J]. Curr Probl Diagn Radiol, 2012, 41(5):149-158.
30	Balasubramanian I, Fleming CA, Corrigan MA, et al. Meta-analysis of the diagnostic accuracy of ultrasound-guided fine-needle aspiration and core needle biopsy in diagnosing axillary lymph node metastasis [J]. Br J Surg, 2018, 105(10):1244-1253.
31	Chen MY, Gillanders WE. Staging of the axilla in breast cancer and the evolving role of axillary ultrasound [J]. Breast Cancer (Dove Med Press), 2021, 13:311-323.
32	Buzatto I, Dos Reis F, de Andrade JM, et al. Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients [J]. World J Surg Oncol, 2021, 19(1):292.
33	Houssami N, Diepstraten SC, Cody HS3rd, et al. Clinical utility of ultrasound-needle biopsy for preoperative staging of the axilla in invasive breast cancer [J]. Anticancer Res, 2014, 34(3):1087-1097.
34	Houssami N, Ciatto S, Turner RM, et al. Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla [J]. Ann Surg, 2011, 254(2):243-251.
35	Caretta-Weyer H, Sisney GA, Beckman C, et al. Impact of axillary ultrasound and core needle biopsy on the utility of intraoperative frozen section analysis and treatment decision making in women with invasive breast cancer [J]. Am J Surg, 2012, 204(3):308-314.
36	Lim GH, Upadhyaya VS, Acosta HA, et al. Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result [J]. Eur J Surg Oncol, 2018, 44(7):945-950.
37	Lim GH, Teo SY, Allen JCJr, et al. Determining whether high nodal burden in early breast cancer patients can be predicted preoperatively to avoid sentinel lymph node biopsy [J]. J Breast Cancer, 2019, 22(1):67-76.
38	Gipponi M, Fregatti P, Garlaschi A, et al. Axillary ultrasound and fine-needle aspiration cytology in the preoperative staging of axillary node metastasis in breast cancer patients [J]. Breast, 2016, 30:146-150.
39	Boughey JC, Moriarty JP, Degnim AC, et al. Cost modeling of preoperative axillary ultrasound and fine-needle aspiration to guide surgery for invasive breast cancer [J]. Ann Surg Oncol, 2010, 17(4):953-958.
40	Pyo JS, Jung J, Lee SG, et al. Diagnostic accuracy of fine-needle aspiration cytology and core-needle biopsy in the assessment of the axillary lymph nodes in breast cancer-a meta-analysis [J]. Diagnostics (Basel), 2020, 10(9)
41	Fujioka T, Mori M, Kubota K, et al. Clinical Usefulness of Ultrasound-Guided Fine Needle Aspiration and Core Needle Biopsy for Patients with Axillary Lymphadenopathy [J]. Medicina (Kaunas), 2021, 57(7)
42	Layfield LJ, Zhang T, Esebua M, et al. Axillary lymph node metastasis: Fine-needle aspiration biopsy sensitivity as a function of node size, percent replacement of lymph node by tumor and tumor deposit size [J]. Diagn Cytopathol, 2021, 49(2):181-186.
43	Rukanskienė D, Veikutis V, Jonaitienė E, et al. Preoperative axillary ultrasound versus sentinel lymph node biopsy in patients with early breast cancer [J]. Medicina (Kaunas), 2020, 56(3):127.
44	Ahn HS, Kim SM, Jang M, et al. Ultrasonography and ultrasound-guided fine-needle aspiration biopsy can predict a heavy nodal metastatic burden in early-stage breast cancer [J]. Ultrasonography, 2021, 40(4):520-529.
45	Tandon M, Ball W, Kirby R, et al. A comparative analysis of axillary nodal burden in ultrasound/biopsy positive axilla vs ultrasound negative sentinel lymph node biopsy positive axilla [J]. Breast Dis, 2019, 38(3-4):93-96.
46	van Wely BJ, de Wilt JH, Francissen C, et al. Meta-analysis of ultrasound-guided biopsy of suspicious axillary lymph nodes in the selection of patients with extensive axillary tumour burden in breast cancer [J]. Br J Surg, 2015, 102(3):159-168.
47	Liberale V, Rosso R, Arisio R, et al. Axillary dissection in patients with preoperative positive nodal cytology: Genuine need or overtreatment? [J]. Breast J, 2020, 26(2):168-175.
48	Farrell TP, Adams NC, Stenson M, et al. The Z0011 Trial: Is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients? [J]. Eur Radiol, 2015, 25(9):2682-2687.
49	中国医师协会超声医师分会. 中国超声造影临床应用指南 [M]. 北京: 人民卫生出版社, 2017: 31-33.
50	Nielsen Moody A, Bull J, Culpan AM, et al. Preoperative sentinel lymph node identification, biopsy and localisation using contrast enhanced ultrasound (CEUS) in patients with breast cancer: a systematic review and meta-analysis [J]. Clin Radiol, 2017, 72(11):959-971.
51	Shimazu K, Ito T, Uji K, et al. Identification of sentinel lymph nodes by contrast-enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals [J]. Cancer Med, 2017, 6(8):1915-1922.
52	Xu YL, Liu XJ, Zhu Y, et al. Preoperative localization of sentinel lymph nodes using percutaneous contrast-enhanced ultrasonography in patients with breast cancer [J]. Gland Surg, 2022, 11(2):369-377.
53	Sever AR, Mills P, Jones SE, et al. Preoperative sentinel node identification with ultrasound using microbubbles in patients with breast cancer [J]. AJR Am J Roentgenol, 2011, 196(2):251-256.
54	Luo J, Feng L, Zhou Q, et al. The value of contrast-enhanced ultrasound in determining the location of sentinel lymph nodes in breast cancer [J]. Cancer Imaging, 2021, 21(1):28.
55	Liu YB, Xia M, Li YJ, et al. Contrast-Enhanced Ultrasound in Locating Axillary Sentinel Lymph Nodes in Patients with Breast Cancer: A Prospective Study [J]. Ultrasound Med Biol, 2021, 47(6):1475-1483.
56	Piscaglia F, Bolondi L, Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations [J]. Ultrasound Med Biol, 2006, 32(9):1369-1375.
57	Poanta L, Serban O, Pascu I, et al. The place of CEUS in distinguishing benign from malignant cervical lymph nodes: a prospective study [J]. Med Ultrason, 2014, 16(1):7-14.
58	Du LW, Liu HL, Gong HY, et al. Adding contrast-enhanced ultrasound markers to conventional axillary ultrasound improves specificity for predicting axillary lymph node metastasis in patients with breast cancer [J]. Br J Radiol, 2021, 94(1118):20200874.
59	Steppan I, Reimer D, Müller-Holzner E, et al. Breast cancer in women: evaluation of benign and malignant axillary lymph nodes with contrast-enhanced ultrasound [J]. Ultraschall Med, 2010, 31(1):63-67.
60	Huang S, Zhao Y, Jiang X, et al. Clinical Utility of Contrast-enhanced Ultrasound for the Diagnosis of Lymphadenopathy [J]. Ultrasound Med Biol, 2021, 47(4):869-879.
61	Leborgne R, Leborgne FJr, Leborgne JH. Soft-tissue radiography of axillary nodes with fatty infiltration [J]. Radiology, 1965, 84(3):513-515.
62	Valente SA, Levine GM, Silverstein MJ, et al. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging [J]. Ann Surg Oncol, 2012, 19(6):1825-1830.
63	Baltzer PA, Dietzel M, Burmeister HP, et al. Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? evaluation of an extended protocol in an initial prospective study [J]. AJR Am J Roentgenol, 2011, 196(5):W641-647.
64	Abe H, Schacht D, Kulkarni K, et al. Accuracy of axillary lymph node staging in breast cancer patients: an observer-performance study comparison of MRI and ultrasound [J]. Acad Radiol, 2013, 20(11):1399-1404.
65	Reig B, Lewin AA, Du L, et al. Breast MRI for Evaluation of Response to Neoadjuvant Therapy [J]. Radiographics, 2021, 41(3):665-679.
66	Zhou P, Wei Y, Chen G, et al. Axillary lymph node metastasis detection by magnetic resonance imaging in patients with breast cancer: A meta-analysis [J]. Thorac Cancer, 2018, 9(8):989-996.
67	Mortellaro VE, Marshall J, Singer L, et al. Magnetic resonance imaging for axillary staging in patients with breast cancer [J]. J Magn Reson Imaging, 2009, 30(2):309-312.
68	Murray AD, Staff RT, Redpath TW, et al. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes [J]. Br J Radiol, 2002, 75(891):220-228.
69	Choi HY, Park M, Seo M, et al. Preoperative axillary lymph node evaluation in breast cancer: current issues and literature review [J]. Ultrasound Q, 2017, 33(1):6-14.
70	Atallah D, Moubarak M, Arab W, et al. MRI-based predictive factors of axillary lymph node status in breast cancer [J]. Breast J, 2020, 26(11):2177-2182.
71	Kim WH, Kim HJ, Park CS, et al. Axillary Nodal Burden Assessed with Pretreatment Breast MRI Is Associated with Failed Sentinel Lymph Node Identification after Neoadjuvant Chemotherapy for Breast Cancer [J]. Radiology, 2020, 295(2):275-282.
72	Arslan G, Altintoprak KM, Yirgin IK, et al. Diagnostic accuracy of metastatic axillary lymph nodes in breast MRI [J]. Springerplus, 2016, 5(1):735.
73	Memarsadeghi M, Riedl CC, Kaneider A, et al. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging [J]. Radiology, 2006, 241(2):367-377.
74	Luciani A, Dao TH, Lapeyre M, et al. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results [J]. AJR Am J Roentgenol, 2004, 182(4):1059-1067.
75	Hyun SJ, Kim EK, Yoon JH, et al. Adding MRI to ultrasound and ultrasound-guided fine-needle aspiration reduces the false-negative rate of axillary lymph node metastasis diagnosis in breast cancer patients [J]. Clin Radiol, 2015, 70(7):716-722.
76	Fogante M, Tagliati C, De Lisa M, et al. Correlation between apparent diffusion coefficient of magnetic resonance imaging and tumor-infiltrating lymphocytes in breast cancer [J]. Radiol Med, 2019, 124(7):581-587.
77	Yılmaz E, Erok B, Atca AÖ. Measurement of apparent diffusion coefficient in discrimination of benign and malignant axillary lymph nodes [J]. Pol J Radiol, 2019, 84:e592-592e597.
78	Guvenc I, Whitman GJ, Liu P, et al. Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients [J]. Breast J, 2019, 25(1):47-55.
79	De Cataldo C, Bruno F, Palumbo P, et al. Apparent diffusion coefficient magnetic resonance imaging (ADC-MRI) in the axillary breast cancer lymph node metastasis detection: a narrative review [J]. Gland Surg, 2020, 9(6):2225-2234.
80	Samiei S, Smidt ML, Vanwetswinkel S, et al. Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer [J]. Eur Radiol, 2020, 30(8):4212-4222.
81	Ramírez-Galván YA, Cardona-Huerta S, Elizondo-Riojas G, et al. Does axillary lymph node size predict better metastatic involvement than apparent diffusion coefficient (ADC) value in women with newly diagnosed breast cancer? [J]. Acta Radiol, 2020, 61(11):1494-1504.
82	Perri M, Grattacaso G, di Tunno V, et al. T2 shine-through phenomena in diffusion-weighted MR imaging of lumbar discs after oxygen-ozone discolysis: a randomized, double-blind trial with steroid and O2-O3 discolysis versus steroid only [J]. Radiol Med, 2015, 120(10):941-950.
83	Kuijs VJ, Moossdorff M, Schipper RJ, et al. The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review [J]. Insights Imaging, 2015, 6(2):203-215.
84	Le Boulc'h M, Gilhodes J, Steinmeyer Z, et al. Pretherapeutic Imaging for Axillary Staging in Breast Cancer: A Systematic Review and Meta-Analysis of Ultrasound, MRI and FDG PET [J]. J Clin Med, 2021, 10(7)
85	Ko H, Baghdadi Y, Love C, et al. Clinical Utility of 18F-FDG PET/CT in Staging Localized Breast Cancer Before Initiating Preoperative Systemic Therapy [J]. J Natl Compr Canc Netw, 2020, 18(9):1240-1246.
86	Di Micco R, Santurro L, Gasparri ML, et al. PET/MRI for Staging the Axilla in Breast Cancer: Current Evidence and the Rationale for SNB vs. PET/MRI Trials [J]. Cancers (Basel), 2021, 13(14)
87	Huellner MW, Appenzeller P, Kuhn FP, et al. Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations [J]. Radiology, 2014, 273(3):859-869.
88	Catalano OA, Rosen BR, Sahani DV, et al. Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients--a hypothesis-generating exploratory study [J]. Radiology, 2013, 269(3):857-869.
89	Morawitz J, Bruckmann NM, Dietzel F, et al. Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer [J]. Eur J Nucl Med Mol Imaging, 2022, 49(3):992-1001.
90	van Nijnatten T, Goorts B, Vöö S, et al. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study [J]. Eur J Nucl Med Mol Imaging, 2018, 45(2):179-186.
91	Pilewskie M, Morrow M. Axillary Nodal Management Following Neoadjuvant Chemotherapy: A Review [J]. JAMA Oncol, 2017, 3(4):549-555.
92	Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial [J]. JAMA, 2013, 310(14):1455-1461.
93	Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study [J]. Lancet Oncol, 2013, 14(7):609-618.
94	Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study [J]. J Clin Oncol, 2015, 33(3):258-264.
95	Shin K, Weaver O, Wei W, et al. Sonographic features of benign and malignant axillary nodes post-neoadjuvant chemotherapy [J]. Breast J, 2020, 26(2):182-187.
96	Le-Petross HT, McCall LM, Hunt KK, et al. Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance) [J]. AJR Am J Roentgenol, 2018, 210(3):669-676.
97	Boughey JC, Ballman KV, Hunt KK, et al. Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the american college of surgeons oncology group Z1071 trial (Alliance) [J]. J Clin Oncol, 2015, 33(30):3386-3393.
98	Kim WH, Kim HJ, Park HY, et al. Axillary pathologic complete response to neoadjuvant chemotherapy in clinically node-positive breast cancer patients: a predictive model integrating the imaging characteristics of ultrasound restaging with known clinicopathologic characteristics [J]. Ultrasound Med Biol, 2019, 45(3):702-709.
99	Kim R, Chang JM, Lee HB, et al. Predicting axillary response to neoadjuvant chemotherapy: breast mri and us in patients with node-positive breast cancer [J]. Radiology, 2019, 293(1):49-57.
100	Gregory A, Denis M, Bayat M, et al. Predictive value of comb-push ultrasound shear elastography for the differentiation of reactive and metastatic axillary lymph nodes: a preliminary investigation [J]. PLoS One, 2020, 15(1):e0226994.
101	Stadnik TW, Everaert H, Makkat S, et al. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings [J]. Eur Radiol, 2006, 16(10):2153-2160.
102	Gentilini O, Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND) [J]. Breast, 2012, 21(5):678-681.
103	Reimer T, Stachs A, Nekljudova V, et al. Restricted axillary staging in clinically and sonographically node-negative early invasive breast cancer (c/iT1-2) in the context of breast conserving therapy: first results following commencement of the intergroup-sentinel-mamma (INSEMA) Trial [J]. Geburtshilfe Frauenheilkd, 2017, 77(2):149-157.
104	van Roozendaal LM, Vane M, van Dalen T, et al. Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08) [J]. BMC Cancer, 2017, 17(1):459.
105	Sun S, Mutasa S, Liu MZ, et al. Deep learning prediction of axillary lymph node status using ultrasound images [J]. Comput Biol Med, 2022, 143:105250.
106	Wang Z, Sun H, Li J, et al. Preoperative prediction of axillary lymph node metastasis in breast cancer using CNN based on multiparametric MRI [J]. J Magn Reson Imaging, 2022, 56(3):700-709.

[1]	Qi Lyu, Pinjing Hui, Yafang Ding, Yanhong Yan. Carotid contrast-enhanced ultrasound assessment of plaque vulnerability and its correlation with ischemic stroke [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(10): 1040-1045.
[2]	Lei Ding, Wen Luo, Xiao Yang, Lina Pang, Peidi Zhang, Haijing Liu, Jiani Yuan, Jin Liu. Application of high-frame-rate contrast-enhanced ultrasound in evaluation of imaging features of C-TIRADS 4-5 thyroid nodules [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 887-894.
[3]	Qian Zhang, Jiahui Chen, Xuemeng Gao, Aoxue Zhao, Ying Huang. Value of radiomics features based on high-frame-rate contrast-enhanced ultrasound in differential diagnosis of benign and malignant thyroid nodules [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 895-903.
[4]	Lianhua Zhu, Xiang Fei, Peng Han, Bo Jiang, Nan Li, Yukun Luo. Value of high frame rate contrast-enhanced ultrasound in differential diagnosis of gallbladder polyp lesions [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 904-910.
[5]	Miao Li, Lianhua Zhu, Peng Han, Bo Jiang, Xiang Fei. Evaluation of relationsip between vascular morphology and risk factors for hepatocellular carcinoma by high-frame-rate contrast-enhanced ultrasound [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 911-915.
[6]	Weiping Zhang, Jingling Wang, Zhixing Liu, Li Chen, Fangqun Chen. Characteristics of time-intensity curve of high-frame-rate contrast-enhanced ultrasound in clear cell renal cell carcinoma [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 916-922.
[7]	Jianmin Ding, Zhengyi Qin, Xiang Zhang, Yan Zhou, Hongyu Zhou, Yandong Wang, Xiang Jing. Contrast-enhanced ultrasound versus gadoxetic acid-enhanced magnetic resonance imaging for LI-RADS classification of focal liver lesions ≤3 cm in patients at high risk of hepatocellular carcinoma: a prospective study [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 930-938.
[8]	Dan Han, Ting Wang, Huan Xiao, Lirong Zhu, Jingyu Chen, Yi Tang. Diagnostic value of contrast enhanced ultrasound versus contrast enhanced computed tomography in benign and malignant liver lesions in children [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 939-944.
[9]	Tingting Liu, Yanbing Lin, Shan Wang, Murong Chen, Zijian Tang, Dongling Dai, Bei Xia. Evaluation of metabolic dysfunction-associated fatty liver disease in children by ultrasound-guided attenuation parameter [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 787-794.
[10]	Yanbo Ma, Yang Hua, Guimei Liu, Xiufeng Meng, Liping Cui. Risk factors for carotid atherosclerotic lesions in middle adults [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 822-826.
[11]	Yaping Jia, Shu'e Zeng. Ultrasound and pathological characteristics of breast metaplastic carcinoma containing squamous cell carcinoma components [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 844-848.
[12]	Hua Shao, Ziyue Na, Hui Jing, Bo Li, Qiucheng Wang, Wen Cheng. Value of preoperative percutaneous contrast-enhanced ultrasound in diagnosis of axillary sentinel lymph node metastasis and burden in breast cancer [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 849-853.
[13]	bing Feng, Qiuguo Zou, Zhenbo Liang, Yanming Lu, Yi Zeng, Shumiao Wu. Clinical study of ultrasonic signs and molecular biological indicators of senile non-specific invasive breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 48-51.
[14]	Yansong Li, Huimin Feng, Mingchao Liu, Zepeng Liu, Qiuxia Jiang. Expression and clinical significance of STIP1 in triple negative breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 52-56.
[15]	Wenyi Zhao, Bingzi Zou, Guanhui Cai, Yongzhi Liu, Hong Wen. Application of ultrasound strain elastography combined with MRI-DWI guided targeted puncture in diagnosis of prostate lesions [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(9): 988-994.

Please choose a citation manager

Content to export